1. Home
  2. ELME vs KALA Comparison

ELME vs KALA Comparison

Compare ELME & KALA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Elme Communities

ELME

Elme Communities

HOLD

Current Price

$2.05

Market Cap

191.9M

Sector

Real Estate

ML Signal

HOLD

Logo KALA BIO Inc.

KALA

KALA BIO Inc.

HOLD

Current Price

$2.25

Market Cap

172.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ELME
KALA
Founded
1960
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
191.9M
172.0M
IPO Year
1994
2017

Fundamental Metrics

Financial Performance
Metric
ELME
KALA
Price
$2.05
$2.25
Analyst Decision
Hold
Buy
Analyst Count
4
3
Target Price
$12.67
$31.50
AVG Volume (30 Days)
1.1M
1.2M
Earning Date
05-12-2026
04-15-2026
Dividend Yield
707.44%
N/A
EPS Growth
N/A
67.39
EPS
N/A
N/A
Revenue
$206,360,000.00
N/A
Revenue This Year
$5.03
N/A
Revenue Next Year
$4.31
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.98
$0.07
52 Week High
$17.68
$20.58

Technical Indicators

Market Signals
Indicator
ELME
KALA
Relative Strength Index (RSI) 46.58 59.31
Support Level $1.99 $0.32
Resistance Level $2.19 $3.96
Average True Range (ATR) 0.03 0.37
MACD 0.00 -0.07
Stochastic Oscillator 70.00 7.27

Price Performance

Historical Comparison
ELME
KALA

About ELME Elme Communities

Elme Communities is a real estate investment trust engaged in owning and operating properties in the greater Washington DC metropolitan area. The company's real estate portfolio is comprised of office, retail, and multifamily properties located near transportation nodes. It derives nearly all of its income in the form of rental revenue from tenants organized into long-term leases. The company's office assets contribute the majority of this income, while the rest is split fairly evenly between its retail and multifamily locations. Elme Communities' tenants are banking, consulting, law, and financial services firms. The company operates in a single reportable segment which includes the ownership, development, redevelopment and acquisition of apartment communities.

About KALA KALA BIO Inc.

Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.

Share on Social Networks: